Innovation Showcase Finalist at Animal Microbiome Congress 2019

Embion, a Pre-Series B company seeking up to £2 million

Business Description

As antibiotics are withdrawn from livestock production, producers are looking for cost-effective alternatives. Embion’s technology enables the commercialization of prebiotics, the nutrition for the microbiome, at affordable producer prices.

About the Speaker:

Mark Blackwell is responsible for the Strategy and Business Development managing collaborations with Embion’s partners. As a veterinarian Mark started his career in animal health but has experience of a wide range of industries including advanced materials, chemicals and human nutrition as a member of DuPont’s Health and Protection Leadership team. Working in both large and small organisations, Mark has had successful leadership roles in innovation, product management, marketing, sales, supply chain and business transformation. He now runs his own management consulting business focussing on these disciplines as well as supporting life- science start-ups. Mark is a Cambridge University graduate with executive education from Wharton Business School.

Core Technology or Product

Embion has developed a unique, patented form of catalysis, proven at 5 litre reactor scale in the laboratory, and about to develop at pilot facility scale prior with commercialisation planned by 2020.

Using food side-streams, the sustainable process is effectively agnostic on biomass source, targeting available materials rich in desired oligosaccharide types. Further, the embedded catalyst is reusable, with simplified purification steps.

By addressing both animal and human nutrition, Embion may leverage insights across species for the development of increasingly targeted prebiotics creating a positive impact on the microbiome.

Poultry field trials are in progress around the world to demonstrate economic returns with other species being targeted.

Click here for more information about the event

Embion in the top 8 most promising, emerging companies in Animal Nutrition

We are proud to kick-off the new year with some very promising news:

Embion is among the 8 most promising, emerging companies in Animal Nutrition, selected to present by a group of leading industry experts in the following event: Animal Health Investment Europe, taking place in London 26-27 February 2019.

Congratulations to the team! We look forward to meet you there!


Visit the event webpage

Embion participates in the 4th Annual European Microbiome Congress

Embion participates in the 4th Annual European Microbiome Congress. The Annual European Microbiome Congress has become a trusted learning and networking platform for leading academics, practicing clinicians, pharmaceutical and nutrition companies, biotech entrepreneurs and investors, government and regulatory bodies and industry leaders who require insight into the latest microbiome research, clinical trials and multi-disciplinary collaborations.

Join us for 2.5 days of intense networking, unpublished research and translational case studies. On the13th we have a pre-conference workshop day and the 14th-15th is the main conference.

To learn more, click here

Embion in the Finalists of Hi Europe 2018

The most exciting innovations are coming from small startups who are largely unknown to the wider industry.

Now in its third year, the Fi Global Startup Innovation Challenge 2018 will give startups the opportunity to pitch their idea to the whole host of F&B industry players that make up the show’s 500+ exhibitors and 10,000+ attendees.

The shortlisted startups will pitch live between 15.45 and17.30 on Tuesday 27 November 2018 at the Industry Insights Theatre. The winners will receive their award following the live pitches.

All shortlisted startups will have access to the Startup Lounge at the Industry Insights Theatre, to meet and network with visitors to Hi Europe. They will also have listings in the Hi Europe show catalogue and on ingredients Network, Fi Global’s online product directory.

This year’s categories are:

  • Most Innovative Healthy Food or Beverage Ingredient
  • Most Innovative Plant-Based Finished Product
  • Most Innovative Technology or Service Supporting F&B


Read More Here

Embion among top innovative startups selected to participate in Seedstars World Bangkok

Embion among 4 innovative Vaud-based startups selected to participate in Seedstars World Bangkok.

It was a great opportunity to explore this vibrant Asian market and thanks to the accelerator program we have a lot of work to do going back in Switzerland.

Innovaud supported and covered the communications of the event. A big thank you for the overall very positive experience!

See how the event unfolded in pictures


Seedstars World promotes, connects and invests up to $1 Million in emerging market startups through its exclusive startup competition in over 60+ countries.



Embion participates at the EPFL Forum 2018 - Come and meet us

Embion patricipates in Switzerland’s largest recruitment fair and one of Europe's largest that will take place for its 36th edition from 8 to 12 October 2018 in Lausanne, Switzerland.

Read more about career opportunities at Embion

Embion receives 1st investors award at Forum 5i

End of May, Embion competed among 19 other start-ups from Switzerland, Italy and France at the 21st Forum 5i and won the 1st place of the Investors Award for the most innovative project.

read more

Embion in the finalists of MassChallenge Switzerland 2018

Embion is one of the 106 high-impact startups selected by MassChallenge Switzerland that will join the final stage of acceleration and benefit from world-class mentorship, programming, and resources. The finalists were selected from more than 1,000 applicants from around the world – making the 2018 cohort MassChallenge Switzerland’s most competitive program to date.

read more